BioWorld MedTech

Sep. 28, 2016

View Archived Issues

DEAL BOOSTS AMBULATORY SURGICAL OFFERINGS

Boston Scientific (NYSE: BSX) has agreed to buy Endochoice Holdings, an Alpharetta, Ga.-based company focused on endoscopy, in a deal valued at about $210 million. Read More

Expanding DCB market expected to exceed $800 million by 2020

Read More

India weighs mandatory UCPMP to curb unfair marketing practices

Read More

Mainstay Medical launches IDE trial to test 'pacemaker for back pain'

Read More

In final guidance, FDA says it wants tests of communication for patient preference data

Read More

Other news to note

Read More

Financings

Read More

Daily M&A

Read More

Product briefs

Read More

Appointments & advancements

Read More

MDD's Oncology Extra

Read More